Suxibuzone
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
4-[ [4-butyl-3,5-dioxo-1,2-di(phenyl)pyrazolidin-4-yl]methoxy]-4-oxobutanoic acid | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Identifiers | |
| ATC code | M02AA22 (WHO) QM01AA90 |
| PubChem | CID 5362 |
| ChemSpider |
5169 |
| UNII |
86TDZ5WP2B |
| KEGG |
D01289 |
| ChEMBL |
CHEMBL1414320 |
| Chemical data | |
| Formula | C24H26N2O6 |
| Molar mass | 438.47304 g/mol |
| |
| |
| | |
Suxibuzone is a drug used for joint and muscular pain. It is a prodrug of the non steroidal anti inflammatory drug phenylbutazone, and is commonly used in horses.
| ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Sunday, April 03, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
